144480505 |
144480528 |
8 |
+ |
25494202 |
A375 |
resistance to PLX-4720 (puromycin) |
TGAGACAGAGTCTTGCTCTGTAG |
PPP1R16A |
ENSG00000160972 |
0.4888228337382956 |
[6,118] |
[1,37] |
2 |
dCas9-VP64 |
positive selection |
2387141 |
144483040 |
144483063 |
8 |
- |
25494202 |
A375 |
resistance to PLX-4720 (puromycin) |
CACCTGTAATTCCAGCACTTTGG |
PPP1R16A |
ENSG00000160972 |
1.9829372138366936 |
[192,253] |
[363,12] |
7 |
dCas9-VP64 |
positive selection |
2430136 |
144485002 |
144485025 |
8 |
+ |
25494202 |
A375 |
resistance to PLX-4720 (puromycin) |
CGCCTGTCATCCCAGCACTTCGG |
PPP1R16A |
ENSG00000160972 |
0.325764302965428 |
[325,99] |
[107,3] |
1 |
dCas9-VP64 |
positive selection |
2474046 |
144480505 |
144480528 |
8 |
+ |
25494202 |
A375 |
resistance to PLX-4720 (zeocin) |
TGAGACAGAGTCTTGCTCTGTAG |
PPP1R16A |
ENSG00000160972 |
-0.01585891051551286 |
[50,117] |
[22,29] |
0 |
dCas9-VP64 |
positive selection |
2482396 |
144483040 |
144483063 |
8 |
- |
25494202 |
A375 |
resistance to PLX-4720 (zeocin) |
CACCTGTAATTCCAGCACTTTGG |
PPP1R16A |
ENSG00000160972 |
2.0349420860207257 |
[143,154] |
[35,352] |
8 |
dCas9-VP64 |
positive selection |
2525391 |
144485002 |
144485025 |
8 |
+ |
25494202 |
A375 |
resistance to PLX-4720 (zeocin) |
CGCCTGTCATCCCAGCACTTCGG |
PPP1R16A |
ENSG00000160972 |
-0.37865692505671 |
[209,516] |
[60,117] |
-4 |
dCas9-VP64 |
positive selection |
2569301 |
144478061 |
144478084 |
8 |
+ |
27661255 |
K562 |
viability |
GCGCGGGGCCCACTGACCCGCGG |
PPP1R16A |
ENSG00000160972 |
0.2807013427578492 |
[524,543] |
[567,475] |
8 |
dCas9-KRAB |
negative selection |
5503660 |
144478416 |
144478439 |
8 |
- |
27661255 |
K562 |
viability |
GCCTCAGCCAGCAACGCCCAAGG |
PPP1R16A |
ENSG00000160972 |
-0.01635712199629935 |
[535,503] |
[442,383] |
0 |
dCas9-KRAB |
negative selection |
5503661 |